Clarivate CLVT Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Academia & Government Group | $295M-2.5% | $312.3M-8.9% | $332.5M+3.5% | $318.5M-7.5% | $302.7M-4.7% | |
| Intellectual Property Group | $197.2M+2.3% | $206.4M-1.3% | $197.8M-1.0% | $202.5M+0.4% | $192.7M-4.1% | |
| Life Sciences & Healthcare | $93.3M-5.1% | $98.3M-11.4% | $92.8M-8.2% | $100.4M-3.6% | $98.3M-4.2% | |
| Royalty And Other Product Expense by Business | ||||||
| Academia & Government Group | $45.1M-18.1% | $47.2M-32.5% | $62.7M+8.7% | $50.4M-15.9% | $55.1M-9.7% | |
| Intellectual Property Group | $15.9M-11.7% | $20.3M+0.5% | $17.9M+4.7% | $19.3M+15.6% | $18M-18.6% | |
| Life Sciences & Healthcare | $8.8M0.0% | $9.6M-5.0% | $9.5M+8.0% | $9.4M-1.1% | $8.8M-4.3% | |
| Other Cost and Expense, Operating by Business | ||||||
| Academia & Government Group | $9.7M+9.0% | $16.2M+68.8% | $11.8M-11.3% | $10.4M-1.9% | $8.9M-15.2% | |
| Intellectual Property Group | $5.7M+9.6% | $5.2M-16.1% | $6.1M-11.6% | $7.1M+4.4% | $5.2M-16.1% | |
| Life Sciences & Healthcare | $3M+20.0% | $1.5M-37.5% | $3.4M-2.9% | $3M-3.2% | $2.5M-24.2% | |
| Adjusted EBITDA by Business | ||||||
| Academia & Government Group | $126.6M+2.3% | $133.1M-10.3% | $146.3M+4.6% | $144.8M-4.8% | $123.8M+0.2% | |
| Intellectual Property Group | $85.4M+8.4% | $88.9M-6.7% | $81.8M-10.1% | $84.6M-5.1% | $78.8M-5.2% | |
| Life Sciences & Healthcare | $29.2M-4.6% | $32.6M-21.6% | $24.3M-27.7% | $32.2M-3.0% | $30.6M+3.0% | |
| Technology Expenses by Business | ||||||
| Academia & Government Group | $21M+7.1% | $19.8M-1.0% | $19.4M+1.0% | $20M-6.1% | $19.6M-2.0% | |
| Intellectual Property Group | $12.8M+4.1% | $12.5M+6.8% | $13.5M+20.5% | $12.6M+5.0% | $12.3M+7.9% | |
| Life Sciences & Healthcare | $6.6M-5.7% | $7M-2.8% | $8M+25.0% | $6.6M-7.0% | $7M+9.4% | |
| Outside Service Expense by Business | ||||||
| Academia & Government Group | $7.3M-19.8% | $8.3M-18.6% | $7.6M-16.5% | $8.8M-12.9% | $9.1M-13.3% | |
| Intellectual Property Group | $4.2M-26.3% | $4.9M-18.3% | $5.1M-3.8% | $5.2M+4.0% | $5.7M+18.8% | |
| Life Sciences & Healthcare | $2M-23.1% | $2.8M-12.5% | $2.2M-37.1% | $3M-3.2% | $2.6M-18.8% | |
| People-Related Expenses by Business | ||||||
| Academia & Government Group | $85.3M-1.0% | $87.7M+3.4% | $84.7M+3.0% | $84.1M-7.1% | $86.2M-6.5% | |
| Intellectual Property Group | $73.2M+0.7% | $74.6M+7.0% | $73.4M+7.5% | $73.7M+2.4% | $72.7M-0.8% | |
| Life Sciences & Healthcare | $43.7M-6.6% | $44.8M-3.7% | $45.4M+0.2% | $46.2M-4.1% | $46.8M-7.9% | |
| Restructuring costs by Business | ||||||
| Academia & Government Group | $4.8M-61.0% | $1.3M-13.3% | $3.3M+94.1% | $4.3M+2,250% | $12.3M+208% | |
| Intellectual Property Group | $4.1M-36.9% | $3M+15.4% | $4.4M+2,100% | $1.8M+350% | $6.5M+150% | |
| Life Sciences & Healthcare | $3.1M-47.5% | $500K-58.3% | $4.2M+100% | $3.2M+540% | $5.9M+96.7% | |
| Revenue by Product | ||||||
| Re-occurring Revenues | $108.6M+2.5% | $114.1M+1.9% | $105.3M-1.3% | $108.9M+0.3% | $105.9M+3.3% | |
| Recurring Revenues | $506.1M+2.3% | —— | —— | —— | $494.5M-3.8% | |
| Subscription revenues | $397.5M+2.3% | $405.8M-0.3% | $405.4M-1.4% | $405.7M0.0% | $388.6M-3.6% | |
| Transactional and other revenues | $79.4M-20.0% | $97.1M-32.6% | $112.4M+7.7% | $106.8M-21.5% | $99.2M-14.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Clarivate break its business down?
- Clarivate (CLVT) reports revenue by business across 3 parts — Academia & Government Group, Intellectual Property Group and Life Sciences & Healthcare. Each is extracted from the segment footnotes and tracked over time.
- Where does Clarivate's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Clarivate's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
